Publications 2014

 

Barau C, Braun J, Vincent C, Haim-Boukobza S, Molina JM, Miailhes P, Fournier I, Aboulker JP, Vittecoq D, Duclos-Vallée JC, Taburet AM, Teicher 6; Agence Nationale de Recherche sur le Sida et les hépatites (ANRS) 148 Study Group. Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study. Clin Infect Dis. 2014 Oct 15;59(8):1177-84. doi: 10.1093/cid/ciu515. Epub 2014 Jul 3. Lien PubMed

Cotte L, Braun J, Lascoux-Combe C, Vincent C, Valantin MA, Sogni P, Lacombe K, Neau D, Aumaitre H, Batisse D, de Truchis P, Gervais A, Michelet C, Morlat P, Vittecoq D, Rosa I, Bertucci I, Chevaliez S, Aboulker JP, Molina JM; for the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26 Study Group. Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial. Clin Infect Dis. 2014 Aug 18. Lien PubMed

Desaint C, Durier C, Poda A, Krivine A, Simon F, Bodilis H, Pialoux G, Cuzin L, Poizot-Martin I, Morineau P I, Lelievre JD, Silbermann B, Aoulker JP, Launay O for the ANRS COHVAC Cohort and the Vaccine Research Institute (VRI). Long-term persistence of vaccine-induced HIV seropositivity in healthy volunteers. JAIDS Clin Res 2014, 5:2 Lien

Diane E.T. Bastiaans, Silvia Forcat, Hermione Lyall, Tim R. Cressey, Rawiwan Hansudewechakul, Suparat Kanjanavanit, Antoni Noguera-Julian, Christoph Königs, Jamie R.J. Inshaw, Suwalai Chalermpantmetagul, Yacine Saïdi, Alexandra Compagnucci, Lynda M. Harper, Carlo Giaquinto, Angela P.H. Colbers, and David M. Burger.Pharmacokinetics of paediatric lopinavir/ritonavir tablets in children when dosed twice daily according to FDA weight bands. The Pediatric Infections Disease Journal, March 2014, 33 (3) Lien PubMed

Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet JF, Saïdi Y, Michel ML, Scott-Algara D, Aboulker JP, Pol S; for the ANRS HB02 study group.Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. Gut. 2014 Feb 20. doi: 10.1136/gutjnl-2013-305707 Lien PubMed

Lutsar I, Chazallon C, Carducci FI, Trafojer U, Abdelkader B, Meiffrédy V, Esposito S, Giaquinto C, Heath PT, Ilmoja ML, Katragkou A, Lascoux C, Metsvaht T, Mitsiakos G, Netzer E, Pugni L, Roilides E, Saidi Y, Sarafidis K, Sharland M, Usonis V, Aboulker JP; NeoMero Consortium. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr. 2014 Feb 13 Lien PubMed